HRS-7535 tablet

DRUG4 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and ObesityOverweight or ObesityType 2 Diabetes

Phase 1

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

Active, not recruitingNCT06621316

Shandong Suncadia Medicine Co., Ltd.Overweight or Obesity

Start: 2024-10-30End: 2025-06-30Updated: 2025-04-18

Phase 2

Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity

RecruitingNCT06820099

Shandong Suncadia Medicine Co., Ltd.Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

Start: 2025-04-10End: 2026-12-31Target: 225Updated: 2025-12-29

Phase 3

A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

RecruitingNCT06589765

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes

Start: 2024-09-27End: 2026-07-18Target: 800Updated: 2025-01-09

A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Active, not recruitingNCT06672172

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes

Start: 2024-09-25End: 2026-04-21Updated: 2025-04-23